Clickmer Systems receives €1.1m grant to deliver innovative diagnostic platform for fast pandemic responsiveness

Clickmer Systems and Fraunhofer IMS are set to launch a collaboration project, InfektoFlex, having been granted €1,101,000.00 by Projektträger Jülich (PTJ).

The project is due to commence in spring 2023 and aims to establish a novel diagnostic assay platform that enables a fast response time towards emerging pandemic situations.

The collaboration between Clickmer Systems and Fraunhofer IMS will see Clickmers being combined with optical Nanosensors, to develop a diagnostic assay platform with superior sensitivity and specificity with a faster response time for the detection of societal relevant emerging pathogens.

Optical Nanosensors, which are fluorescent in near infrared light, qualify for low signal-to-noise ratio. Upon binding of a pathogen to the detection structure, the fluorescence of the Nanosensor changes enabling measurement of the binding events.

Dr Ian Kavanagh, CEO of APIS Assay Technologies, said: “We are excited to launch the project InfektoFlex with Fraunhofer IMS. The platform will provide a more cost-efficient and time-saving solution, with a reduction in development costs through a more sustainable process compared to the commonly used ELISA assay systems (which require the usage of animal-derived antibodies).

Clickmer Systems will provide an adaptive and innovative diagnostic platform for pandemic responsiveness with higher reproducibility.”